Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.

NCT00527488 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

BPH

Interventions

DRUG: Degarelix
DRUG: Degarelix
DRUG: Degarelix
DRUG: Degarelix

Sponsor

Ferring Pharmaceuticals